Showing results (281-290 of 398) with videos related to

Sort By:
Pageof 40
Annals of Internal Medicine|January 1, 1985
Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trialR D Hull, J Hirsh, C J Carter, et al.
Pacing and Clinical Electrophysiology : PACE|March 11, 2009
Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillatorsMarlene Robinson, Jeff S Healey, John Eikelboom, et al.
Lancet (London, England)|June 3, 1989
The Canadian American Ticlopidine Study (CATS) in thromboembolic strokeM Gent, J A Blakely, J D Easton, et al.
Blood|November 12, 2010
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO modelNeil A Goldenberg, Alex C Spyropoulos, Jonathan L Halperin, et al.
Thrombosis and Haemostasis|December 8, 2010
Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studiesAlexander G G Turpie, Michael Rud Lassen, Bengt I Eriksson, et al.
The New England Journal of Medicine|September 9, 1999
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study GroupM M Samama, A T Cohen, J Y Darmon, et al.
Circulation|January 1, 1996
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fractureM Gent, J Hirsh, J S Ginsberg, et al.
The New England Journal of Medicine|August 14, 1997
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study GroupM Cohen, C Demers, E P Gurfinkel, et al.
Lancet (London, England)|March 7, 1987
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic strokeA G Turpie, M N Levine, J Hirsh, et al.
The American Journal of Cardiology|September 16, 1998
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary EventsM Cohen, C Demers, E P Gurfinkel, et al.
Pageof 40